Elham Azimi Nekoo

No ORCID on file · 6 papers in corpus
rct 2024
BMC women's health ·doi:10.1186/s12905-024-03337-z

BACKGROUND: The optimal approach to luteal-phase support in infertility treatment remains a subject of debate. This study was conducted to investigate the clinical outcomes, side effects, and patient satisfaction associated with vaginal, su…

nonrandomized-trial 2023
Journal of family & reproductive health ·doi:10.18502/jfrh.v17i3.13539

OBJECTIVE: Platelet Rich Plasma (PRP) is proposed to have important role in cell division and proliferation, angiogenesis and health. This study evaluates the effect of a single injection of autologous PRP on ovarian response markers in wom…

rct 2011
Iranian journal of reproductive medicine

BACKGROUND: General concern is that the pregnancy rate is higher with GnRH-agonist as a protocol of pituitary suppression. GnRH-antagonist protocol provides a shorter period of administration and an easy flexible protocol. OBJECTIVE: In th…

rct 2010
Archives of medical science : AMS ·doi:10.5114/aoms.2010.19306

INTRODUCTION: The aim of the study was to compare the efficacy of half-dose, long-acting GnRH analogue (Diphereline) with Suprefact in IVF/ICSI (in vitro fertilization/intracytoplasmic sperm injection) cycles. MATERIAL AND METHODS: In this…

observational 2009

Background: Endometriosis is one of the most challenging diseases that constitute 20% - 40% of women searching for their infertility diagnosis. Objective: This study was undertaken in order to compare the outcome of in vitro fertilization/i…

rct 2008
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-008-9209-2

OBJECTIVE: To study the efficacy of the aromatase inhibitor letrozole in controlled ovarian hyperstimulation (COH). MATERIAL AND METHODS: In this prospective simply randomized clinical trial, one hundred forty patients with unexplained inf…